Lipitor, Atorvastatin Newswire (Page 5)

Lipitor, Atorvastatin Newswire (Page 5)

Comprehensive Real-Time News Feed for Lipitor, Atorvastatin (generic). (Page 5)

Results 81 - 100 of 752 in Lipitor, Atorvastatin (generic)

  1. Twice-a-year shot may lower cholesterolRead the original story w/Photo

    Nov 15, 2016 | UPI

    Instead of popping a pill every day, people might soon control "bad" LDL cholesterol by getting an injection at their doctor's office two or three times a year. Researchers testing a new injectable drug called Inclisiran found it cut LDL cholesterol by half or more.

    Comment?

  2. Cholesterol drug shows promise in heart diseaseRead the original story w/Photo

    Nov 15, 2016 | Post Register

    For the first time, a new drug given along with a cholesterol-lowering statin medicine has proved able to shrink plaque that is clogging arteries, potentially giving a way to undo some of the damage of heart disease. The difference was very small but doctors hope it will grow with longer treatment, and any reversal or stabilization of disease would be a win for patients and a long-sought goal.

    Comment?

  3. Drug combo reversed plaque buildup in heart patients' arteriesRead the original story w/Photo

    Nov 15, 2016 | The Washington Post

    Lipitor, one of several cholesterol-busting statins, is among the best-selling drugs of all time and used by many millions of Americans. Statins are one of the biggest success stories of modern medicine, credited with transforming cardiac care.

    Comment?

  4. Statins' expanding reach falls short among women, minoritiesRead the original story w/Photo

    Nov 14, 2016 | Los Angeles Times

    Use of cholesterol-lowering statin medications in the United States rocketed upward 80% in the decade between 2002 and 2013. But new research suggests that the drugs shown to prevent heart attacks and strokes remain underused, especially among women, ethnic minorities and the uninsured.

    Comment?

  5. Everyone over 40 should take statins regardless of heart diseaseRead the original story w/Photo

    Nov 14, 2016 | New York Daily News

    That is the sweeping new recommendation released by the U.S. Preventive Services Task Force on Sunday. The new guidelines greatly widen the recommended pool of patients for the cholesterol-reducing drugs to anyone over 40 with one of these risk factors: high cholesterol, high blood pressure, diabetes or a smoking habit.

    Comment?

  6. Statins may help those with cardiovascular disease live longerRead the original story w/Photo

    Nov 14, 2016 | The Washington Post

    Taking cholesterol-lowering drugs known as statins can help prevent cardiovascular disease. For people who already have cardiovascular disease, might high doses of statins be beneficial? The researchers analyzed data on 509,766 adults who had some type of cardiovascular disease caused by plaque buildup in their arteries.

    Comment?

  7. The 20 best-selling drugs in New JerseyRead the original story w/Photo

    Nov 14, 2016 | NJ.com

    Medicare spent $3.9 billion on prescription drugs for New Jersey residents in 2014. But not all of that money was equally distributed.

    Comment?

  8. American Association for Study of Liver Diseases Release: Statins...Read the original story

    Nov 13, 2016 | BioSpace

    American Association for Study of Liver Diseases Release: Statins Shown To Reduce Risk Of Death In People With Alcoholic Cirrhosis /PRNewswire/ -- The use of statins has been shown to significantly decrease risk of death among patients with alcoholic cirrhosis, according to research presented this week at The Liver MeetingA held by the American Association for the Study of Liver Diseases. Alcoholic cirrhosis is an advanced form of liver disease, causing scarring of the liver.

    Comment?

  9. Statins May Up Survival Odds After Cardiac ArrestRead the original story w/Photo

    Nov 12, 2016 | WebMD

    The odds of surviving cardiac arrest seem higher for patients who've been taking cholesterol -lowering statins , a new study shows. Researchers in Taiwan studied the medical records of nearly 138,000 cardiac arrest patients.

    Comment?

  10. New guidelines issued for statin drug therapyRead the original story

    Nov 13, 2016 | Journal Gazette

    The U.S. Preventive Services Task Force on Sunday issued new guidance for the use of cholesterol-busting statin drugs.

    Comment?

  11. Why statins really DO work: Higher doses cut the risk of early...Read the original story w/Photo

    Nov 9, 2016 | Daily Mail

    High dose statins slash the risk of dying by 30 per cent compared to normal pills, a major study has found. The majority of patients on statins take dose of between 5 to 40 micrograms a day, depending on the type of tablet.

    Comment?

  12. High-intensity statins linked to better survival rates of cardiovascular patientsRead the original story w/Photo

    Nov 9, 2016 | PhysOrg Weblog

    A large national study has confirmed the value of high-intensity statin treatments for people with cardiovascular disease, according to researchers at the Stanford University School of Medicine. Over the duration of a year, the researchers found that patients taking high-intensity statins had an increased chance of survival over those on moderate-intensity statins.

    Comment?

  13. Higher intensity of statin therapy associated with lower risk of...Read the original story w/Photo

    Nov 8, 2016 | EurekAlert!

    Among more than 500,000 patients with atherosclerotic cardiovascular disease, researchers found an inverse association between intensity of statin therapy and mortality, with patients who received high-intensity statins having the greatest reductions in risk of death, according to a study published online by JAMA Cardiology . Statin therapy remains the cornerstone for the prevention of atherosclerotic cardiovascular disease .

    Comment?

  14. Pfizer discontinues work on bococizumabRead the original story

    Nov 5, 2016 | Chemical and Engineering News

    Higher sales, lower income, and a drug discontinued add up to a 5-cent drop in projected 2016 per-share earnings. Source: Pfizer Higher sales, lower income, and a drug discontinued add up to a 5-cent drop in projected 2016 per-share earnings.

    Comment?

  15. Everyday Cheapskate: Seven ways to cut the high cost of prescription drugsRead the original story w/Photo

    Nov 4, 2016 | Red Bluff Daily News

    These days the skyrocketing cost of prescription drugs is enough to give you a heart attack. If your prescription medication costs have got you down, cheer up.

    Comment?

  16. Regeneron Revenue Growth SlowsRead the original story w/Photo

    Nov 4, 2016 | Wall Street Journal

    U.S. sales of the drug Eylea increased 16% to $854 million, compared with $734 million in the prior-year quarter. The company now expects Eylea to post between 23% and 25% revenue growth for the year, raising the low end of its forecast by 3 percentage points.

    Comment?

  17. Dyslipidemia Drugs Market at a CAGR of -10.3% from 2015 to 2023Read the original story w/Photo

    Nov 2, 2016 | SBWire

    Dyslipidemia is a chronic metabolic disease, characterized by abnormal amount of low density lipoprotein, high density lipoprotein and triglyceride levels. Abnormal lipid level is also one of the major risk factor for the cardiovascular diseases such as atherosclerosis, hypertension and others.

    Comment?

  18. Pfizer Soft Earnings the Latest Reason to Avoid Big Pharma StocksRead the original story w/Photo

    Nov 2, 2016 | TheStreet.com

    The Big Pharma kingpin lowered its expectations for the full year and announced that it would stop development of a new cholesterol drug. Tuesday wasn't kind to Pfizer and its stock, with shares in the Big Pharma giant plummeting 2.05% following downbeat earnings for the third quarter.

    Comment?

  19. Pfizer's 3Q bitter pill: Profit falls, drug scrappedRead the original story w/Photo

    Nov 2, 2016 | NWAonline

    Drugmaker Pfizer topped off a difficult third quarter with news that it's scrapping a closely watched experimental cholesterol drug, partly because of expectations insurers would limit access so much that it wouldn't make much money, a possible bad omen for the pharmaceutical industry. The biggest U.S.-based drugmaker on Tuesday reported its quarterly profit plunged 38 percent as higher spending and a slew of acquisition-related charges more than offset higher sales.

    Comment?

  20. Pfizer profit plunges, cholesterol drug droppedRead the original story w/Photo

    Nov 1, 2016 | SFGate

    Pfizer's reports that it saw profit slide during the third quarter as it changed strategies and dropped an expensive cholesterol drug. Pfizer's reports that it saw profit slide during the third quarter as it changed strategies and dropped an expensive cholesterol drug.

    Comment?